These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 38977625)

  • 1. Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice.
    Hamidi SH; Etebar N; Rahimzadegan M; Zali A; Roodsari SR; Niknazar S
    Mol Cell Biochem; 2024 Jul; 479(7):1643-1671. PubMed ID: 38977625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis.
    Kråkenes T; Sandvik CE; Ytterdal M; Gavasso S; Evjenth EC; Bø L; Kvistad CE
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis.
    Baharlooi H; Nouraei Z; Azimi M; Moghadasi AN; Tavassolifar MJ; Moradi B; Sahraian MA; Izad M
    Scand J Immunol; 2021 Jun; 93(6):e13013. PubMed ID: 33338274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes.
    Guy R; Offen D
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
    Barati S; Tahmasebi F; Faghihi F
    Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis.
    Shokati A; Naser Moghadasi A; Nikbakht M; Sahraian MA; Mousavi SA; Ai J
    Stem Cell Res Ther; 2021 Jul; 12(1):400. PubMed ID: 34256857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system.
    Zhang J; Buller BA; Zhang ZG; Zhang Y; Lu M; Rosene DL; Medalla M; Moore TL; Chopp M
    Exp Neurol; 2022 Jan; 347():113895. PubMed ID: 34653510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.
    Yousefi F; Lavi Arab F; Saeidi K; Amiri H; Mahmoudi M
    J Neuroimmunol; 2019 Mar; 328():20-34. PubMed ID: 30557687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
    Mansoor SR; Zabihi E; Ghasemi-Kasman M
    Life Sci; 2019 Oct; 235():116830. PubMed ID: 31487529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: A new strategy to overcome cell therapy limitations.
    Hazrati A; Malekpour K; Soudi S; Hashemi SM
    Biomed Pharmacother; 2022 Aug; 152():113211. PubMed ID: 35696942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in stem cell therapy in the treatment of multiple sclerosis.
    Zolfaghari Baghbadorani P; Rayati Damavandi A; Moradi S; Ahmadi M; Bemani P; Aria H; Mottedayyen H; Rayati Damavandi A; Eskandari N; Fathi F
    Rev Neurosci; 2023 Aug; 34(6):613-633. PubMed ID: 36496351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.
    Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes from human umbilical cord Mesenchymal stem cells attenuates stress-induced hippocampal dysfunctions.
    Niu Y; Wang X; Li M; Niu B
    Metab Brain Dis; 2020 Dec; 35(8):1329-1340. PubMed ID: 32761493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins.
    Yoon YM; Lee JH; Song KH; Noh H; Lee SH
    J Pineal Res; 2020 Apr; 68(3):e12632. PubMed ID: 31989677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases.
    Gorabi AM; Kiaie N; Barreto GE; Read MI; Tafti HA; Sahebkar A
    Mol Neurobiol; 2019 Dec; 56(12):8157-8167. PubMed ID: 31197655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach.
    Yari H; Mikhailova MV; Mardasi M; Jafarzadehgharehziaaddin M; Shahrokh S; Thangavelu L; Ahmadi H; Shomali N; Yaghoubi Y; Zamani M; Akbari M; Alesaeidi S
    Stem Cell Res Ther; 2022 Aug; 13(1):423. PubMed ID: 35986375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD.
    Lai P; Chen X; Guo L; Wang Y; Liu X; Liu Y; Zhou T; Huang T; Geng S; Luo C; Huang X; Wu S; Ling W; Du X; He C; Weng J
    J Hematol Oncol; 2018 Dec; 11(1):135. PubMed ID: 30526632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Studies and Clinical Trials with Mesenchymal Stem Cell for Demyelinating Diseases: A Systematic Review.
    Esmaeilizade Z; Mohammadi B; Omrani MD; Ghaderian SMH; Rajabibazl M; Fazeli Z
    Curr Stem Cell Res Ther; 2021; 16(8):1005-1017. PubMed ID: 33557738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.